Bora CDMO Bora CDMO

X

Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Aubagio on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

left grey arrow
right gray arrow
  • TABLET;ORAL - 14MG
  • TABLET;ORAL - 7MG
Flag France
Digital Content Digital Content
URL Supplier Web Content
6794410*PED
2027-03-12
202992
2
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
Flag France
Digital Content Digital Content
URL Supplier Web Content
9186346*PED
2034-08-04
202992
2
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
Flag France
Digital Content Digital Content
URL Supplier Web Content
9186346
2034-02-04
U-1786
202992
TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS WHILE MANAGING THE RISK OF TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION BY LIMITING THE
1
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
Flag France
Digital Content Digital Content
URL Supplier Web Content
6794410*PED
2027-03-12
202992
1
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
Flag France
Digital Content Digital Content
URL Supplier Web Content
8802735*PED
2031-03-14
202992
2
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
Flag France
Digital Content Digital Content
URL Supplier Web Content
8802735*PED
2031-03-14
202992
1
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
Flag France
Digital Content Digital Content
URL Supplier Web Content
6794410
2026-09-12
U-1285
202992
TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS
2
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
Flag France
Digital Content Digital Content
URL Supplier Web Content
8802735
Y
2030-09-14
202992
1
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
Flag France
Digital Content Digital Content
URL Supplier Web Content
9186346*PED
2034-08-04
202992
1
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
Flag France
Digital Content Digital Content
URL Supplier Web Content
8802735
Y
2030-09-14
202992
2
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
Flag France
Digital Content Digital Content
URL Supplier Web Content
6794410
2026-09-12
U-1285
202992
TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS
1
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
Flag France
Digital Content Digital Content
URL Supplier Web Content
9186346
2034-02-04
U-1786
202992
TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS WHILE MANAGING THE RISK OF TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION BY LIMITING THE
2
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY